Cargando…
Genotoxicity and Mutagenicity of Inosine Pranobex
INTRODUCTION: Inosine pranobex (Methisoprinol, ISO, Isoprinosine) is an immuno-modulatory antiviral drug that has been licensed since 1971 in several countries worldwide. In humans, the drug is approved for the treatment of viral infections, and it might also have therapeutic use in animals. The aim...
Autores principales: | Tobólska, Sylwia, Terpiłowska, Sylwia, Jaroszewski, Jerzy, Siwicki, Andrzej Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200294/ https://www.ncbi.nlm.nih.gov/pubmed/30364916 http://dx.doi.org/10.2478/jvetres-2018-0030 |
Ejemplares similares
-
Influence of Inosine Pranobex on Cell Viability in Normal Fibroblasts and Liver Cancer Cells
por: Tobólska, Sylwia, et al.
Publicado: (2018) -
Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro
por: Majewska, Anna, et al.
Publicado: (2016) -
A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients
por: Kovachev, Stefan Miladinov
Publicado: (2021) -
Chromium(III) and iron(III) inhibits replication of DNA and RNA viruses
por: Terpiłowska, Sylwia, et al.
Publicado: (2017) -
Azithromycin/inosine-pranobex off label use: Lack of efficacy: case report
Publicado: (2022)